Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) just unveiled an update.
Zhongzhi Pharmaceutical Holdings Limited has announced a board meeting scheduled for March 26, 2025, to discuss and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider the payment of a final dividend for 2024, indicating potential financial distributions to stakeholders.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
YTD Price Performance: -6.06%
Average Trading Volume: 300,964
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$796.2M
For an in-depth examination of 3737 stock, go to TipRanks’ Stock Analysis page.